🇺🇸 FDA
Patent

US 12102640

Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

granted A61KA61K31/40A61K31/4439

Quick answer

US patent 12102640 (Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration) held by United States Government as represented by the Department of Veterans Affairs expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/40, A61K31/4439, A61K31/444, A61K31/445